Lv32
258 积分 2022-07-12 加入
Clinical Pharmacology and Translational Science Considerations in the Development of Dual‐Payload Antibody Drug Conjugates
2小时前
已完结
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
4小时前
已完结
Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation
7小时前
已完结
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
1天前
已完结
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
1天前
已完结
Photostability of Topoisomerase I Inhibitor Conjugated IgG1 Antibody–Drug Conjugates: Characterization Study and Degradation Mechanism Analysis
9天前
已完结
Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis
13天前
已完结
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
24天前
已完结
Evaluation of Double Self-Immolative Linker-Based Antibody–Drug Conjugate FDA022-BB05 with Enhanced Therapeutic Potential
1个月前
已完结
Cathepsin B-Responsive Phosphatidylinositol 3-Kinase (PI3K) Prodrug for the Treatment of Pulmonary Fibrosis
1个月前
已完结
皖公网安备34019202002308
